Longitudinal Retinal Changes in MOGAD

Oertel, FC; Sotirchos, ES; Zimmermann, HG; Motamedi, S; Specovius, S; Asseyer, ES; Chien, C; Cook, L; Vasileiou, E; Filippatou, A; Calabresi, PA; Saidha, S; Pandit, L; D'Cunha, A; Outteryck, O; Zephir, H; Pittock, S; Flanagan, EP; Bhatti, MT; Rommer, PS; Bsteh, G; Zrzavy, T; Kuempfel, T; Aktas, O; Ringelstein, M; Albrecht, P; Ayzenberg, I; Pakeerathan, T; Knier, B; Aly, L; Asgari, N; Soelberg, K; Marignier, R; Tilikete, CF; Calvo, AC; Villoslada, P; Sanchez-Dalmau, B; Martinez-Lapiscina, EH; Llufriu, S; Green, AJ; Yeaman, MR; Smith, TJ; Brandt, AU; Chen, J; Paul, F; Havla, J

Paul, F (通讯作者),Charite Univ Med Berlin, Charitepl 1, D-10117 Berlin, Germany.

ANNALS OF NEUROLOGY, 2022; 92 (3): 476

Abstract

Objective Patients with myelin oligodendrocyte glycoprotein antibody (MOG-IgG)-associated disease (MOGAD) suffer from severe optic neuritis (ON) leadi......

Full Text Link